Infect Immun 2009,77(8):3258–3263.PubMedCrossRef 15. Domenech P, Kolly GS, Leon-Solis L, Fallow A, Reed MB: Massive gene duplication Alpelisib event among clinical isolates of the Mycobacterium tuberculosis W/Beijing family. J Bacteriol 2010,192(18):4562–4570.PubMedCrossRef 16. Reed MB, Gagneux S, Deriemer K, Small PM, Barry CE: The W-Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and has the DosR dormancy regulon constitutively upregulated. J Bacteriol 2007,189(7):2583–2589.PubMedCrossRef 17. Respicio L, Nair PA, Huang Q, Anil B, Tracz S, Truglio JJ, Kisker C, Raleigh DP, Ojima I, Knudson DL, et al.: Characterizing

septum inhibition in Mycobacterium tuberculosis for novel drug discovery. Tuberculosis (Edinb) 2008,88(5):420–429.CrossRef 18. Huang Q, Kirikae F, Kirikae T, Pepe A, Amin A, Respicio L, Slayden RA, Tonge PJ, Ojima I: Targeting FtsZ for antituberculosis drug discovery: noncytotoxic taxanes as novel antituberculosis agents. J Med Chem 2006,49(2):463–466.PubMedCrossRef 19.

Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE, Gemcitabine research buy et al.: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. BIIB057 solubility dmso Nature 1998,393(6685):537–544.PubMedCrossRef 20. Rezwan M, Grau T, Tschumi A, Sander P: Lipoprotein synthesis in mycobacteria. Microbiology 2007,153(Pt 3):652–658.PubMedCrossRef 21. Chauhan A, Lofton H, Maloney E, Moore J, Fol M, Madiraju MV, Rajagopalan M: Interference of Mycobacterium tuberculosis cell division by Rv2719c, a cell wall hydrolase. Mol Microbiol 2006,62(1):132–147.PubMedCrossRef 22. Chauhan A, Madiraju MV, Fol M, Lofton H, Maloney E, Reynolds R, Rajagopalan M: Mycobacterium Adenosine tuberculosis cells growing in macrophages are filamentous and deficient in FtsZ rings. J Bacteriol 2006,188(5):1856–1865.PubMedCrossRef 23. Rustad TR, Sherrid AM,

Minch KJ, Sherman DR: Hypoxia: a window into Mycobacterium tuberculosis latency. Cell Microbiol 2009,11(8):1151–1159.PubMedCrossRef 24. Zhang Y, Hatch KA, Wernisch L, Bacon J: A Bayesian Change point model for differential gene expression patterns of the DosR regulon of Mycobacterium tuberculosis. BMC Genomics 2008, 9:87.PubMedCrossRef 25. Park HD, Guinn KM, Harrell MI, Liao R, Voskuil MI, Tompa M, Schoolnik GK, Sherman DR: Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol 2003,48(3):833–843.PubMedCrossRef 26. Bartek IL, Rutherford R, Gruppo V, Morton RA, Morris RP, Klein MR, Visconti KC, Ryan GJ, Schoolnik GK, Lenaerts A, Voskuil MI: The DosR regulon of M. tuberculosis and antibacterial tolerance. Tuberculosis (Edinb) 2009,89(4):310–316.CrossRef 27. Converse PJ, Karakousis PC, Klinkenberg LG, Kesavan AK, Ly LH, Allen SS, Grosset JH, Jain SK, Lamichhane G, Manabe YC, et al.